[1]
|
De Groot, L.J. (1975) Thyroid Carcinoma. Medical Clinics of North America, 59, 1233-1246.
https://doi.org/10.1016/S0025-7125(16)31971-X
|
[2]
|
Graceffa, G., Patrone, R., Vieni, S., Campanella, S., Calamia, S., Laise, I., Conzo, G., Latteri, M. and Cipolla, C. (2019) Association between Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma: A Retrospective Analysis of 305 Patients. BMC Endocrine Disorders, 19, Article No. 26. https://doi.org/10.1186/s12902-019-0351-x
|
[3]
|
Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B. and Roliński, J. (2015) Immune Disorders in Hashimoto’s Thyroiditis: What Do We Know So Far? Journal of Immunology Research, 2015, Article ID: 979167.
https://doi.org/10.1155/2015/979167
|
[4]
|
高嘉良, 袁方均, 武伦, 高云龙, 苟志敏. 桥本甲状腺炎对甲状腺乳头状癌的影响[J]. 锦州医科大学学报, 2021, 42(3): 83-86. https://doi.org/10.13847/j.cnki.lnmu.2021.03.017
|
[5]
|
Intidhar, L.S., Chaabouni, A.M., Kraiem, T., Attia, N., Gritli, S., El May, A. and Ben Slimane, F. (2006) Carcinome de la thyroïde et thyroïdite de Hashimoto [Thyroid Carci-noma and Hashimoto Thyroiditis]. Annales d’oto-laryngologie et de Chirurgie Cervico Faciale, 123, 175-178. (In French) https://doi.org/10.1016/S0003-438X(06)76662-2
|
[6]
|
Dailey, M.E., Lindsay, S. and Skahen, R. (1955) Relation of Thyroid Neoplasms to Hashimoto Disease of the Thyroid Gland. Archives of Surgery, 70, 291-297. https://doi.org/10.1001/archsurg.1955.01270080137023
|
[7]
|
Hussain, S.P. and Haris, C.C. (2007) Inflammation and Cancer: An Aryist Link with Novel Potentials. International Journal of Cancer, 121, 2373-2380. https://doi.org/10.1002/ijc.23173
|
[8]
|
Jankovic, B., Le, K.T. and Hershman, J.M. (2013) Clinical Review: Hash-imoto’s Thyroiditis and Papillary Thyroid Carcinoma: Is There a Correlation? The Journal of Clinical Endocrinology & Metabolism, 98, 474-482.
https://doi.org/10.1210/jc.2012-2978
|
[9]
|
Tokić, S., Štefanić, M., Karner, I. and Glavaš-Obrovac, L. (2017) Al-tered Expression of CTLA-4, CD28, VDR, and CD45 mRNA in T Cells of Patients with Hashimoto’s Thyroiditis—A Pilot Study. Endokrynologia Polska, 68, 274-828.
https://doi.org/10.5603/EP.2017.0020
|
[10]
|
刘三保, 陈斌. 桥本甲状腺炎合并甲状腺癌与免疫细胞的相关性研究进展[J]. 辽宁医学院学报, 2015, 36(3): 107-109.
|
[11]
|
Zahran, A.M., Sayed, M.M., Shafik, E.A., Khallaf, S.M., Mohamed, W.M. and Hetta, H.F. (2019) The Frequency and Clinical Implications of Lymphocyte Subsets and Circulat-ing Plasma Cells in Newly Diagnosed Multiple Myeloma Patients. Egyptian Journal of Immunology, 26, 117-131.
|
[12]
|
Lyu, Y., Song, M., Tian, X., Yu, X., Liang, N. and Zhang, J. (2020) Impact of Radiotherapy on Circulat-ing Lymphocyte Subsets in Patients with Esophageal Cancer. Medicine (Baltimore), 99, e20993.
https://doi.org/10.1097/MD.0000000000020993
|
[13]
|
Ben-Skowronek, I., Szewczyk, L., Kulik-Rechberger, B. and Korobowicz, E. (2013) The Differences in T and B Cell Subsets in Thyroid of Children with Graves’ Disease and Hashimoto’s Thyroiditis. World Journal of Pediatrics, 9, 245-250. https://doi.org/10.1007/s12519-013-0398-0
|
[14]
|
Xu, X., Wang, R., Su, Q., Huang, H., Zhou, P., Luan, J., Liu, J., Wang, J. and Chen, X. (2016) Expression of Th1- Th2- and Th17-Associated Cytokines in Laryngeal Carcinoma. On-cology Letters, 12, 1941-1948.
https://doi.org/10.3892/ol.2016.4854
|
[15]
|
寿岚, 任跃忠. 桥本甲状腺炎的免疫学研究进展[J]. 浙江医学, 2014, 36(4): 343-345.
|
[16]
|
叶旺. 合并桥本氏甲状腺炎的甲状腺乳头状癌的临床病理特点及颈部淋巴结转移风险分析[D]: [硕士学位论文]. 南宁: 广西医科大学, 2019.
|
[17]
|
朱利国, 浦洪波, 武红玉, 李跃松, 陈永伟. 促甲状腺激素、甲状腺过氧化物酶抗体和促甲状腺激素受体抗体检测在甲状腺疾病中的应用价值[J]. 标记免疫分析与临床, 2010, 17(4): 241-243.
|
[18]
|
Liu, Y., Lyu, H., Zhang, S., Shi, B. and Sun, Y. (2021) The Impact of Coexistent Hashimo-to’s Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Frontiers in Endo-crinology (Lausanne), 12, Article ID: 772071. https://doi.org/10.3389/fendo.2021.772071
|
[19]
|
郑旭东. 桥本氏病患者血清促甲状腺激素水平升高对甲状腺组织癌变的影响[J]. 实用癌症杂志, 2018, 33(3): 395-397.
|
[20]
|
Liang, J., Zeng, W., Fang, F., Yu, T., Zhao, Y., Fan, X., Guo, N. and Gao, X. (2017) Clinical Analysis of Hashimoto Thyroidi-tis Coexistent with Papillary Thyroid Cancer in 1392 Patients. Acta Otorhinolaryngologica Italica, 37, 393-400.
https://doi.org/10.14639/0392-100X-1709
|
[21]
|
彭学姣, 许天敏, 张琨, 赵生炳, 史莹, 常伟勤. 雌激素与甲状腺癌相关性的研究进展[J]. 现代肿瘤医学, 2018, 26(11): 1791-1794.
|
[22]
|
王贵生, 赵金凤. 雌激素受体在自身免疫性甲状腺炎中的表达[J]. 中国误诊学杂志, 2008(10): 2298-2299.
|
[23]
|
Ikawa, S., Fukui, M., Ueyama, Y., Tamao-ki, N., Yamamoto, T. and Toyoshima, K. (1988) B-raf, a New Member of the Raf Family, Is Activated by DNA Rear-rangement. Molecular and Cellular Biology, 8, 2651-2654.
https://doi.org/10.1128/MCB.8.6.2651
|
[24]
|
王欣怡, 白俊文. 甲状腺癌的相关基因BRAF、RET、RAS研究新进展[J]. 重庆医学, 2018, 47(36): 4631-4634.
|
[25]
|
Rhoden, K.J., Unger, K., Salvatore, G., Yilmaz, Y., Vovk, V., Chiappetta, G., Qumsiyeh, M.B., Rothstein, J.L., Fusco, A., Santoro, M., Zitzelsberger, H. and Tallini, G. (2006) RET/Papillary Thyroid Cancer Rearrangement in Nonneoplastic Thyrocytes: Follicular Cells of Hashimoto’s Thyroiditis Share Low-Level Recombination Events with a Subset of Papillary Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 91, 2414-2423.
https://doi.org/10.1210/jc.2006-0240
|
[26]
|
姜海霞, 李艳波. 碘对甲状腺疾病影响及机制的研究进展[J]. 中华实用诊断与治疗杂志, 2016, 30(7): 639-641.
https://doi.org/10.13507/j.issn.1674-3474.2016.07.006
|
[27]
|
Iddah, M.A. and Macharia, B.N. (2013) Autoimmune Thyroid Disorders. ISRN Endocrinology, 2013, Article ID: 509764. https://doi.org/10.1155/2013/509764
|
[28]
|
董芬, 张彪, 单广良. 中国甲状腺癌的流行现状和影响因素[J]. 中国癌症杂志, 2016, 26(1): 47-52.
|
[29]
|
Hatch, M., Furukawa, K., Brenner, A., Olinjyk, V., Ron, E., Zablotska, L., Terekhova, G., McConnell, R., Markov, V., Shpak, V., Ostroumova, E., Bouville, A. and Tronko, M. (2010) Prevalence of Hyperthyroidism after Exposure during Childhood or Adolescence to Radioiodines from the Chornobyl Nuclear Accident: Dose-Response Results from the Ukraini-an-American Cohort Study. Radiation Research, 174, 763-772. https://doi.org/10.1667/RR2003.1
|